Reply to: Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations exclude differentials

Código QR

Reply to: Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations exclude differentials

Guardado en:

Detalles Bibliográficos
Autores principales:	Karolina Kania, Wojciech Ambrosius, Elzbieta Tokarz Kupczyk, Wojciech Kozubski
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/c410a92235334c66b3d0c0102612db68
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations thoroughly exclude differentials
por: Josef Finsterer
Publicado: (2021)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih Cucunawangsih, et al.
Publicado: (2021)

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
por: Samir Andrade Mendonça, et al.
Publicado: (2021)

Excluded
por: David Asai
Publicado: (2020)

IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
por: Elrazi Ali, et al.
Publicado: (2021)

Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2
por: Hansam Cho, et al.
Publicado: (2021)

Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation
por: Sarah Kreps, et al.
Publicado: (2021)

A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Mitch Brinkkemper, et al.
Publicado: (2021)

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
por: Nikolaos C. Kyriakidis, et al.
Publicado: (2021)

Viral vector-based vaccines against SARS-CoV-2
por: Kenneth Lundstrom
Publicado: (2021)

Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
por: Chaojie Zhong, et al.
Publicado: (2021)

Headache Attributed to SARS-CoV-2 Infection or COVID-19 Related Headache—Not Migraine-like Problem-Original Research
por: Aleksandra Kacprzak, et al.
Publicado: (2021)

Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
por: Rebecca L. Brocato, et al.
Publicado: (2021)

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
por: Ian McDonald, et al.
Publicado: (2021)

Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination
por: Rafael Assis, et al.
Publicado: (2021)

Successful Anti-SARS-CoV-2 Spike Protein Antibody Response to Vaccination in Deficiency
por: Maaz Jalil DO, et al.
Publicado: (2021)

The vaccination threshold for SARS-CoV-2 depends on the indoor setting and room ventilation
por: A. Mikszewski, et al.
Publicado: (2021)

Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines
por: Emilio Sánchez-Álvarez, et al.
Publicado: (2021)

Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain
por: Ignacio Barandalla, et al.
Publicado: (2021)

Acute Myocarditis Following mRNA-1273 SARS-CoV-2 VaccinationNovel Teaching Points
por: Curtis B. Williams, MD, et al.
Publicado: (2021)

Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?
por: Alberto Cereda, et al.
Publicado: (2021)

Reply to Hudaib
por: Leo Chen, et al.
Publicado: (2021)

DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
por: Kit Man Chai, et al.
Publicado: (2021)

Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic
por: Charles Yap, et al.
Publicado: (2021)

Considering Frailty in SARS-CoV-2 Vaccine Development: How Geriatricians Can Assist
por: Andrew MK, et al.
Publicado: (2021)

The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
por: Jing Zou, et al.
Publicado: (2021)

Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection.
por: Morgane Rolland, et al.
Publicado: (2021)

Reply to McDonald, “Protections against the Risk of Airborne SARS-CoV-2 Infection”
por: Leslie Dietz, et al.
Publicado: (2020)

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
por: Claudio Counoupas, et al.
Publicado: (2021)

MEASLES IN YEKATERINBURG: THE HISTORICAL PATH FROM THE PERIOD BEFORE VACCINATION TO THE STAGE OF ELIMINATION OF THE INFECTION
por: A. A. Golubkova, et al.
Publicado: (2018)

An 88-year-old woman with acute disseminated encephalomyelitis following messenger ribonucleic acid-based COVID-19 vaccination
por: Mai Shimizu, et al.
Publicado: (2021)

Efficacy (and safety) of vaccination against SARS-CoV-2 in cancer patients on active treatment
por: Tina Zupančič, et al.
Publicado: (2021)

Excluding Emotions: The Performative Function of Populism
por: Emmy Eklundh
Publicado: (2020)

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation
por: Lauren M. Meyers, et al.
Publicado: (2021)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP
por: José Zúñiga, et al.
Publicado: (2021)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
por: Yandi Zhang, et al.
Publicado: (2021)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
por: Felipe Melo-González, et al.
Publicado: (2021)

Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
por: Ghareghani Majid, et al.
Publicado: (2021)

Reply: Variability in motor threshold
por: Gonçalo Cotovio, et al.
Publicado: (2021)

The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal
por: Eduardo Tosta
Publicado: (2021)